Integer Holdings Co. (NYSE:ITGR) Holdings Lifted by KBC Group NV

KBC Group NV boosted its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 83.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,598 shares of the medical equipment provider’s stock after acquiring an additional 726 shares during the quarter. KBC Group NV’s holdings in Integer were worth $212,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Contravisory Investment Management Inc. boosted its holdings in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares during the period. Huntington National Bank boosted its stake in shares of Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 268 shares during the period. Versant Capital Management Inc grew its holdings in shares of Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 183 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Integer by 74.1% in the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 278 shares during the last quarter. Finally, Larson Financial Group LLC raised its holdings in shares of Integer by 20,000.0% during the third quarter. Larson Financial Group LLC now owns 1,005 shares of the medical equipment provider’s stock worth $131,000 after acquiring an additional 1,000 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Performance

ITGR opened at $139.44 on Wednesday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The stock’s 50 day moving average price is $137.90 and its two-hundred day moving average price is $130.70. The firm has a market capitalization of $4.68 billion, a P/E ratio of 43.04, a price-to-earnings-growth ratio of 1.81 and a beta of 1.13. Integer Holdings Co. has a 12-month low of $94.56 and a 12-month high of $146.36.

Analyst Upgrades and Downgrades

ITGR has been the topic of several research reports. Truist Financial upped their target price on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Piper Sandler reiterated an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a research note on Friday, October 25th. KeyCorp increased their price target on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Citigroup lifted their price objective on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Finally, Benchmark increased their target price on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $146.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.